These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32932379)

  • 1. Fusion of Preinterventional MR Imaging With Liver Perfusion CT After RFA of Hepatocellular Carcinoma: Early Quantitative Prediction of Local Recurrence.
    Kobe A; Kindler Y; Klotz E; Puippe G; Messmer F; Alkadhi H; Pfammatter T
    Invest Radiol; 2021 Mar; 56(3):188-196. PubMed ID: 32932379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
    Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
    Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Real-time CT/MRI-US Automatic Fusion System Based on Vascular Matching in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: A Prospective Study.
    Han S; Lee JM; Lee DH; Yoon JH; Chang W
    Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1579-1596. PubMed ID: 34312690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial.
    Lee DH; Lee MW; Kim PN; Lee YJ; Park HS; Lee JM
    Radiology; 2021 Oct; 301(1):229-236. PubMed ID: 34313474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience.
    Marquez HP; Puippe G; Mathew RP; Alkadhi H; Pfammatter T; Fischer MA
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):90-98. PubMed ID: 27812781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
    Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
    AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
    Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
    World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Minami Y; Minami T; Hagiwara S; Ida H; Ueshima K; Nishida N; Murakami T; Kudo M
    Eur Radiol; 2018 May; 28(5):1986-1993. PubMed ID: 29196855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Lee MW; Kang D; Lim HK; Cho J; Sinn DH; Kang TW; Song KD; Rhim H; Cha DI; Lu DSK
    Eur Radiol; 2020 Apr; 30(4):2391-2400. PubMed ID: 31900708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small masses (≤3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation.
    Cha DI; Song KD; Kang TW; Lee MW; Rhim H
    Br J Radiol; 2020 Jan; 93(1105):20190719. PubMed ID: 31670571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.